Depression and Anxiety Trial, Recruiting NCT07691749 Sponsor: Dr Sadia yasir Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07691749
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with major depressive disorder (a formal diagnosis made using standard psychiatric guidelines)
  • People aged between 18 and 60 years old
  • People of any gender
  • People who are able to speak and understand Urdu or English
  • People who have been taking a stable, unchanged dose of a type of antidepressant called an SSRI (selective serotonin reuptake inhibitor) by mouth for at least two weeks before joining the study
  • People whose depression scores above a certain level on a standard 17-question depression assessment tool administered by a clinician (confirm with trial site)

Who may not be able to join:

  • People who have certain other serious mental health conditions, such as schizophrenia, bipolar disorder, or a substance use disorder
  • People with a weakened immune system, including those currently receiving chemotherapy, organ transplant recipients, or people living with conditions such as HIV/AIDS
  • People who are taking long-term medications on an ongoing basis, particularly anti-inflammatory drugs, or who have taken antibiotics within the last two weeks
  • People who are pregnant or currently breastfeeding
  • People who are currently taking probiotic or prebiotic supplements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sadia Yasir, MBBS FCPS, Jinnah hospital lahore/ Allama Iqbal Medical college lahore, Pakistan

Phone: +923314567690

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Dr Sadia yasir
Registry
ClinicalTrials.gov
Start date
31 January 2026
Est. completion
25 December 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Change in Hamilton Depression Rating Scale-17 (HDRS-17) Total Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov